Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Financing Activities: 2016-2021

Historic Cash from Financing Activities for ENDRA Life Sciences (NDRA) over the last 3 years, with Dec 2021 value amounting to $321,076.

  • ENDRA Life Sciences' Cash from Financing Activities fell 94.24% to $321,076 in Q4 2021 from the same period last year, while for Dec 2021 it was $19.0 million, marking a year-over-year increase of 59.78%. This contributed to the annual value of $7.8 million for FY2024, which is 3.87% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Cash from Financing Activities of $321,076 as of Q4 2021, which was down 35.35% from $496,606 recorded in Q3 2021.
  • Over the past 5 years, ENDRA Life Sciences' Cash from Financing Activities peaked at $12.6 million during Q1 2021, and registered a low of $39,238 during Q1 2020.
  • Over the past 3 years, ENDRA Life Sciences' median Cash from Financing Activities value was $2.5 million (recorded in 2019), while the average stood at $3.7 million.
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Cash from Financing Activities was 31,970.75% (2021), while the steepest drop was 94.24% (2021).
  • Over the past 5 years, ENDRA Life Sciences' Cash from Financing Activities (Quarterly) stood at $8.5 million in 2017, then plummeted by 89.05% to $7.7 million in 2018, then decreased by 24.45% to $5.8 million in 2019, then declined by 4.67% to $5.6 million in 2020, then slumped by 94.24% to $321,076 in 2021.
  • Its Cash from Financing Activities was $321,076 in Q4 2021, compared to $496,606 in Q3 2021 and $12.6 million in Q1 2021.